FDA investigates possible Vytorin link to cancer

(AP) -- Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news138692479.html">FDA investigates possible Vytorin link to cancer</a></p> <p>(AP) -- Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.</p>